东北制药: management transactions · France · AMF SZSE:000597 FR FR · AMF Mcap 7.4Bn€
Browse the full directors' dealings record of 东北制药, a listed equity based in France. Shares are quoted on FR FR, under the supervision of AMF. Market capitalisation: €7.4bn. The latest transaction was filed on 31 May 2022 (Purchase). Among the most active insiders: 郑伟. Every trade is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 7.07 Bn€
Gross profit 2.64 Bn€ 37% margin
Net income 260.1 M€ 3.7% margin
Balance sheet & cash
Market cap 7.45 Bn€
Total debt 2.15 Bn€
Free Cash Flow 1.01 Bn€
Last declaration on 31 May 2022
Declarations 9 total
Executives ● Purchase25 SZSE
36,000 shares
SZSE:173000005558279000 · 31 May 2022
Ideal exit: 25 Feb 2023 (T+270) Executives ● Purchase22 SZSE
100 shares
SZSE:173000005553620700 · 25 May 2022
Ideal exit: 19 Feb 2023 (T+270) Executives ● Purchase11 SZSE
11,000 shares
SZSE:173000005542938500 · 20 May 2022
Ideal exit: 14 Feb 2023 (T+270) Executives ● Purchase11 SZSE
18,600 shares
SZSE:173000005539586050 · 19 May 2022
Ideal exit: 13 Feb 2023 (T+270) Executives ● Purchase11 SZSE
19,700 shares
SZSE:173000005491264160 · 28 Apr 2022
Ideal exit: 23 Jan 2023 (T+270) Executives ● Purchase18 SZSE
50,000 shares
SZSE:173000005173966850 · 15 Dec 2021
Ideal exit: 11 Sept 2022 (T+270) Executives ● Purchase7 SZSE
30,000 shares
SZSE:173000005167089500 · 13 Dec 2021
Ideal exit: 9 Sept 2022 (T+270) Executives ● Purchase7 SZSE
110,000 shares
SZSE:173000005118990820 · 29 Nov 2021
Ideal exit: 26 Aug 2022 (T+270) Executives ● Purchase22 SZSE
3,200 shares
SZSE:173000005118990720 · 29 Nov 2021
Ideal exit: 26 Aug 2022 (T+270)
